Drug distributor, Medtech has finally changed its name to Bridgefort Capital Limited.
The change of name follows resolutions passed at an extraordinary general meeting (EGM) of the company held in November last year, which altered the capital structure at MedTech.
Newly appointed Company Secretary Sithulisiwe Ncube said, “The change of name from MedTech Holdings Limited to BridgeFort Capital Limited has been duly approved and effected.”
“The resolutions, mostly relating to the changes in the capital structure of the company, have been approved and processed by the Registrar of Companies and Other Business Entities.”
Besides the change of name, Bridgefort appointed a new Financial Director Michael Nicholson and Sithulisiwe Ncube on Monday this week.
Nicholson is a Chartered Accountant is a Chartered Accountant with over 20 years of experience in the industry.
Ncube is a registered legal practitioner with 8 years of experience.
Led by Vernon Lapham; Bridgefort directors also include Christian Beddies, William Marere, Oliver Lutz and also Pride Masamba.
The Zimbabwe Stock Exchange (ZSE) will give effect to the change of name from Monday the 13th of June 2022.
